These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 5877333)

  • 1. [Effects of triamterene in combination with other diuretics in liver cirrhosis].
    Polli E
    Minerva Med; 1963 Oct; 54(81 Suppl):3018-23. PubMed ID: 5877333
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of diuretics on the survival of 180 patients with cirrhosis of the liver and ascites].
    Robert M; Portmann B
    Schweiz Med Wochenschr; 1969 Feb; 99(6):178-82. PubMed ID: 5781367
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
    Castagnolo B; De Colibus V; Napolitano L; Aliperta A; Caldarelli G; Abignente F
    Clin Ter; 1977 Dec; 83(6):625-9. PubMed ID: 343976
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diuretics. 47].
    Selchau M
    Pharm Prax; 1970; 9():193-9 concl. PubMed ID: 4922055
    [No Abstract]   [Full Text] [Related]  

  • 5. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S; Reynolds TB
    Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M; Duhalt R; Peña JC
    Rev Invest Clin; 1968; 20(2):165-80. PubMed ID: 5721631
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and biochemical study of the therapeutic effect of the diuretic triamterene in ascitogenic cirrhosis].
    Păunescu-Podanu A; Demirian H; Ionitã C; Georgescu D; Tarachiu A; Anghel R; Rubingher L
    Med Interna (Bucur); 1968 May; 20(5):523-30. PubMed ID: 5735425
    [No Abstract]   [Full Text] [Related]  

  • 8. The physiopathologic basis and limitations of treatment of cirrhotic edema with diuretics retaining potassium.
    Vesin P
    Mater Med Pol; 1974; 6(3):199-201. PubMed ID: 4444335
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with Dytac.
    Weber JC
    Minerva Med; 1963 Oct; 54(81 Suppl):2996-7. PubMed ID: 5877330
    [No Abstract]   [Full Text] [Related]  

  • 10. Ascites in cirrhosis: pathophysiology and management.
    Panos M; Williams R
    Br J Hosp Med; 1988 Oct; 40(4):256, 258, 260-2. PubMed ID: 3228657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of hypokalaemia due to diuretics.
    Leemhuis MP; Struyvenberg A
    Neth J Med; 1973; 16(1):18-28. PubMed ID: 4572424
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative efficacy of spironolactone and hydrochlorothiazide (separately and in combination) in cirrhotic edema.
    Munshi CP; Sawkar LA; Vaidya PM; Gulati OD
    J Assoc Physicians India; 1967 Dec; 15(12):583-9. PubMed ID: 4870785
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P
    Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.
    Radó JP; Sawinsky I; Juhos E
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):163-7. PubMed ID: 1002353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of diuretics on chronic liver disease.
    Steigmann F; Mejicano R
    Am J Gastroenterol; 1969 Jul; 52(1):37-44. PubMed ID: 5796683
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypertension--diuretics as antihypertensive agents].
    Ikeda T
    Nihon Rinsho; 1970 Apr; 28(4):1266-71. PubMed ID: 4913896
    [No Abstract]   [Full Text] [Related]  

  • 17. [The behavior of uricemia during treatment with spironolactone and with other diuretics].
    Bufalari A; Meloni G
    Minerva Med; 1967 Nov; 58(89):3815-22. PubMed ID: 6074933
    [No Abstract]   [Full Text] [Related]  

  • 18. How to treat arterial hypertension.
    Finnerty FA
    Am Fam Physician; 1973 Apr; 7(4):99-108. PubMed ID: 4694341
    [No Abstract]   [Full Text] [Related]  

  • 19. [OBSERVATIONS ON THE CLINICAL USE OF TRIAMTERENE IN TREATMENT OF THE ASCITES OF HEPATIC CIRRHOSIS].
    BORRELLI PL; CAIRELLA M; DEMARTIIS M
    Clin Ter; 1964 Jun; 29():471-5. PubMed ID: 14173216
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V; Porcellati C; Corea L; Todisco T
    Minerva Nefrol; 1968; 15(4):258-60. PubMed ID: 5745815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.